Status
Conditions
Treatments
About
The International Association for the Study of Lung Cancer Staging Committee recently unveiled the ninth edition of TNM staging system for lung cancer. This study aims to explore survival outcomes, stage grouping, and gene mutations in N descriptors of this new classification system.
Enrollment
Sex
Volunteers
Inclusion criteria
Pathological N2.
Exclusion criteria
Patients undergoing neoadjuvant chemotherapy
Loading...
Central trial contact
Fangqiu Fu, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal